MENU
简体中文
ENG
Home
About Us
Our Facilities
SPIRO Site
PINE Site
OBiO Intelli-M
Leadership Team
Laboratory Sciences
CDMO Solutions
Process Development
cGMP Manufacturing
Viral Vector
Oncolytic Virus
Cell Therapy Products
Plasmid & Nucleotides
Quality & Regulatory
Cold Chain Logistics
Innovations
Insights
Press Releases
Events
Knowledge Center
Investor Relations
Contact Us
Enable Gene Therapy For Better Lives
Your Trustful Partner in Research and Manufacturing for Gene and Cell Therapy
Make Gene Delivery Accessible
Side-by-Side Navigation for Your Innovations
Industrialize Your Product At OBiO
End-to-End Offerings with Versatile Technical Platform
For Global Customers
OBiO has launched its state-of-the-art GMP facility Intelli-M in 2023
Providing client-centered and high-quality service as our commitment, we strive to become a world leading gene and cell therapy CRO/CDMO group.
Our Offering
CDMO
Solutions
OBiO offers holistic solutions in process development, analytical method, IND-enabling CMC, clinical and commercial contract manufacturing of viral vector, oncolytic virus, and cell therapy products.
Laboratory
Sciences
OBiO provides an integrated portfolio of plasmid construction, viral packaging, cell biology and animal study services for biomedical researchers.
Our Facilities
SPIRO Site
Integrated Laboratory Services
Process and Analytical Method Development
Research and Development Center
International Medical Park Shanghai, China
OBiO Intelli-M
Process Development & Characterization
Clinical and Commercial Manufacturing
77,000-square-meter Facility for Global Supply
Lin-Gang Free-Trade Zone Shanghai, China
PINE Site
Process and Analytical Method Development
Pre-clinical and Clinical Manufacturing
Three-building, 10,000-square-meter campus
International Medical Park Shanghai, China
Insights
Press Releases
Events
Oct 24,2023
OBiO Announces Strategic Partnership with Refreshgene to Realize Commercialization of Gene Therapy Product
OBiO Technology (Shanghai) Corp., Ltd. (Stock code: SH688238), a world leading contract development and manufacturing organization for cell and gene therapy, officially announced an agreement with Refreshgene Therapeutics (Refreshgene).
Sep 05,2023
OBiO Announces Strategic Partnership with Tofflon to Advance Cell and Gene Therapy Development
OBiO Technology (Shanghai) Corp., Ltd. (Stock code: SH688238) today announced that it entered into a strategic cooperation agreement with today announced that it entered into a strategic cooperation agreement with Shanghai Tofflon Science and Technology Co.Ltd.(Stock code:SZ300171).
Jun 29,2023
FDA Acceptance of Drug Master File Marks New Milestone Achieved for OBiO TECH of GMP Plasmid Products
OBiO Technology (Shanghai) Corp., Ltd (Stock code: SH688238) is a biotechnology company focusing on the cell and gene therapy field. Recently announced that the U.S. Food and Drug Administration (FDA) has successfully obtained the GMP plasmid DNA Drug Master File (DMF) filing.
ALL PRESS RELEASES
10th-12th Oct. ,2023
Cell&Gene meeting on the Mesa
Carlsbad, CA, United States
18th-21st Sep. ,2023
BioProcess International Conference & Exhibition
Boston, MA
16th-20th May ,2023
ASGCT 26th Annual Meeting
Los Angeles, CA
ALL EVENTS
Contact Us
First Name*
Last Name*
Company*
Email*
Phone Number*
I'm interested in…
Please choose
General Inquiry
Laboratory Sciences
Process Development
Analytical/Formulation Development
Non-IND (IIT) Service
IND-Enabling CMC (IND-CMC) Service
Clinical Manufacturing
Commercial Manufacturing
Extended Services (Pre-IND/Post-IND)
Investor Relations
Questions or Comments
Security Code*
I AGREE*
By submitting this form I agree that OBiO may process my data in the manner described in OBiO’s
Privacy Policy
We won’t share your information.
Main
+86 400-151-5198
Tel
+1-408-807-5641
For General Inquiry
oobio@obiosh.com
For Business Inquiry
bd@obiosh.com
Address
446 S Hillview Dr Milpitas, CA 95035 U.S.A
About Us
Laboratory Services
Insights
Innovations
Investor Relations
CDMO Solutions
Process Development
cGMP Manufacturing
Quality & Regulatory
Cold Chain Logistics
Privacy Policy
© 2023 OBiO Technology (Shanghai) Corp., Ltd. All Rights Reserved